Compare EVCM & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVCM | ATRC |
|---|---|---|
| Founded | 2006 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 2021 | 2005 |
| Metric | EVCM | ATRC |
|---|---|---|
| Price | $10.20 | $30.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $10.57 | ★ $51.17 |
| AVG Volume (30 Days) | 130.8K | ★ 627.0K |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 145.45 | 74.74 |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $588,907,000.00 | $201,630,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.03 | $12.42 |
| P/E Ratio | $102.90 | ★ N/A |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $7.66 | $28.32 |
| 52 Week High | $14.41 | $43.18 |
| Indicator | EVCM | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 41.24 | 42.06 |
| Support Level | $9.81 | $28.69 |
| Resistance Level | $10.44 | $32.85 |
| Average True Range (ATR) | 0.74 | 1.18 |
| MACD | -0.13 | 0.25 |
| Stochastic Oscillator | 36.01 | 56.75 |
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.